Precision Oncology Advances with New Clinical Data from GT Biopharma, IDEAYA, Zymeworks, and Regeneron
GT Biopharma, IDEAYA Biosciences, Zymeworks, and Regeneron Pharmaceuticals have each reported progress in oncology trials and approvals, highlighting continued momentum in biomarker-driven cancer treatments.